Zhejiang Sunflower Light Energy

Sunflower's 2026 semi-annual report disclosed on August 27 shows that the company achieved operating revenue of 109 million yuan in the first half of the year, down 24.82% year on year. Net profit attributable to the parent company was a loss of 12.3965 million yuan, swinging from profit to loss year on year and plummeting 1,168.07%. Net profit attributable to the parent company after deducting non-recurring items was a loss of 8.7199 million yuan, plunging 19,561.37% year on year. Net cash flow from operating activities was negative 17.51 million yuan, turning from positive to negative year on year, a decline of 308.37%. The company's main business focuses on the pharmaceutical sector, with main operating revenue consisting of active pharmaceutical ingredients and finished formulations. Sales revenue from active pharmaceutical ingredients fell 26.19% year on year, and sales revenue from finished formulations fell 25.71% year on year, with both core businesses shrinking by more than a quarter. The main factors affecting net profit attributable to the parent company include a decline in main business revenue, a credit impairment loss provision on an investment intention payment to Shanghai Xipu Technology Co., Ltd., as well as payment of an administrative penalty imposed by the Zhejiang Bureau of the China Securities Regulatory Commission, a provision for estimated liabilities from pending litigation, and recognition of compensation losses from concluded litigation. In addition, the book value of inventory increased from 171 million yuan at the beginning of the period to 193 million yuan, up 12.9%, while research and development investment fell sharply by 42.67% year on year to 6.457 million yuan. As of August 27, the company's share price closed at 3.11 yuan per share, with a cumulative decline of 49.27% for the year, already halved.

Sunflower (300111.SZ) released its 2026 interim report, swinging from profit to loss, with net profit attributable to the parent company at negative 12.3965 million yuan, a decrease of 13.5572 million yuan compared with the same period last year, down 1168.07% year-on-year. Total operating revenue was 109 million yuan, down 24.82% year-on-year. Net cash inflow from operating activities was negative 17.5095 million yuan, down 308.37% year-on-year. The company's asset-liability ratio was 17.73%, gross margin was 22.15%, ROE was negative 1.85%, and diluted earnings per share was negative 0.01 yuan. The number of shareholders was 80,300, and the top ten shareholders held 34.37% of total share capital.